

share
L-Arginine Acetylsalicylate CAS NO 37466-21-0
Unit Price:
CAS No.:37466-21-0
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
L-Arginine Acetylsalicylate is a pharmaceutically relevant salt formed from the amino acid L-arginine and acetylsalicylic acid (aspirin). This compound is engineered to enhance the solubility and bioavailability profile of aspirin, offering a more targeted therapeutic approach. It is primarily utilized in the pharmaceutical and nutraceutical industries for the development of advanced analgesic, anti-inflammatory, and cardiovascular formulations.
Application
- Pharmaceutical Intermediates: Serves as a key active pharmaceutical ingredient (API) or precursor in the synthesis of novel analgesic and anti-inflammatory drugs.
- Cardiovascular Health Supplements: Incorporated into nutraceutical formulations aimed at supporting vascular health and blood flow regulation.
- Pain Management Solutions: Used in the development of advanced, buffered aspirin products designed for improved gastric tolerance and efficacy.
- Research & Development: A critical compound for biochemical and pharmacological research studying nitric oxide pathways and antiplatelet mechanisms.
- Veterinary Pharmaceuticals: Applied in veterinary medicine for pain relief and anti-inflammatory treatments in animals.
Basic Information
| Product Name | L-Arginine Acetylsalicylate |
| CAS No. | 37466-21-0 |
| Molecular Formula | C13H19N5O6 |
| Molecular Weight | 341.32 g/mol |
| Synonyms | Arginine Aspirin; L-Arginine Acetylsalicylate Salt; Aspirin-Arginine; Arginine Acetylsalicylate; Acetylsalicylic Acid Arginine Salt; 2-Acetoxybenzoic acid compound with L-arginine (1:1); (S)-2-Amino-5-guanidinopentanoic acid acetylsalicylate; Arginate |
| EINECS | Contact for details |
Quality Control
Our L-Arginine Acetylsalicylate is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing to ensure it meets high-purity standards suitable for pharmaceutical applications. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided with every shipment.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and must be kept in a dry environment to prevent degradation.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification (IR) | Conforms to reference spectrum |
| Assay (HPLC) | ≥ 98.0% |
| Loss on Drying | ≤ 1.0% |
| Residue on Ignition | ≤ 0.1% |
| Heavy Metals (as Pb) | ≤ 10 ppm |
| Related Substances (HPLC) | Total impurities ≤ 2.0% |
| Specific Rotation | +21.0° to +24.0° (c=1 in H2O) |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Mefenamic Acid CAS NO 61-68-7


Meclofenamate Sodium CAS NO 6385-02-0


Indometacin CAS NO 53-86-1


Ketoprofen Lysinate CAS NO 57469-78-0


Tiaprofenic Acid CAS NO 33005-95-7


Choline Salicylate CAS NO 2016-36-6


Naproxen CAS NO 22204-53-1


Magnesium Salicylate CAS NO 18917-89-0


Diclofenac Sodium CAS NO 15307-79-6


Ibuprofen CAS NO 15687-27-1


Phenylbutazone Sodium CAS NO 129-18-0


Oxyphenyl Butazone CAS NO 129-20-4


Nibufin CAS NO 1224-64-2


Ibufenac CAS NO 1553-60-2


4,4-Diethyl-1-Phenyl-3,5-Pyrazolidinedione CAS NO 1732-61-2


Benzoral CAS NO 1843-82-9


Glafenic Acid CAS NO 10440-42-3


Tribuzone CAS NO 13221-27-7


Clofenamic Acid CAS NO 13278-36-9


Azapropazone CAS NO 13539-59-8
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






